Evidence map›Paper›PMID 37524838›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2024

Feasibility and outcome of third-generation transcatheter aortic valve implantation in patients with extra-large aortic annulus.

Alexander Hof, Hendrik Wienemann, Verena Veulemans, Sebastian Ludwig, Tanja Katharina Rudolph, Simon Geißen, Elmar Kuhn, Kaveh Eghbalzadeh, Sabine Bleiziffer, Tobias Zeus and 5 more

Abstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alexander HofDepartment of Cardiology, Faculty of Medicine, University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Hendrik WienemannDepartment of Cardiology, Faculty of Medicine, University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Verena VeulemansDivision of Cardiology, Pneumology, and Vascular Medicine, Department of Medicine, University Hospital Duesseldorf, Duesseldorf, Germany.
Sebastian LudwigDepartment of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Tanja Katharina RudolphClinic for General and Interventional Cardiology/Angiology, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany.
Simon GeißenDepartment of Cardiology, Faculty of Medicine, University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Elmar KuhnHeart Center, Department of Cardiothoracic Surgery, University Hospital of Cologne, Cologne, Germany.
Kaveh EghbalzadehHeart Center, Department of Cardiothoracic Surgery, University Hospital of Cologne, Cologne, Germany.
Sabine BleizifferDepartment of Cardiothoracic Surgery, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany.
Tobias ZeusDivision of Cardiology, Pneumology, and Vascular Medicine, Department of Medicine, University Hospital Duesseldorf, Duesseldorf, Germany.
Alexander SedaghatHeart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Niklas SchoferDepartment of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Stephan BaldusDepartment of Cardiology, Faculty of Medicine, University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Matti AdamDepartment of Cardiology, Faculty of Medicine, University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Victor MauriDepartment of Cardiology, Faculty of Medicine, University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. victor.mauri@uk-koeln.de.ORCID http://orcid.org/0000-0003-2678-3501

Funding

Deutsche Forschungsgemeinschaft TRR SFB 259Deutsche Herzstiftung F29/21
6 · The paper itself

Abstract

backgroundMany patients in need for transcatheter aortic valve implantation (TAVI) present with an aortic annulus size larger than recommended by the manufacturer's instructions for use (IFU).

aimsTo investigate procedural and short-term safety and efficacy of TAVI in patients with extra-large annuli (ELA).

methods30-day clinical outcome and valve performance as defined by VARC 3 of 144 patients with an aortic annulus size exceeding the permitted range were compared to a propensity-score matched control cohort of patients with an aortic annulus size consistent with the IFU.

resultsArea and perimeter was 730.4 ± 53.9 mm

conclusionTreatment of ELA patients with third-generation TAVI prostheses is feasible and safe, providing similar device success and complication rates as in matched controls with regular-sized aortic annulus. Post-interventional pacemaker implantation rates were low compared to the control group, yet incidence of moderate PVL remains problematic in ELA patients.

Indexed as

Aortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAortic ValveFeasibility StudiesHumansProsthesis DesignTreatment OutcomeAnnulus anatomyAortic annulusAortic valve stenosisTAVITranscatheter aortic valve implantation

Identifiers

PMID37524838
PMCPMC10808444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.